Hypertension is a significant public health issue, and the World Health Organization (WHO) has defined it as systolic blood pressure equal to or greater than 160 mmHg, and/or diastolic blood pressure equal to or greater than 95 mmHg. Those with systolic pressure under 160 mmHg but diastolic pressure between 90-94 mmHg, or with systolic pressure between 141-159 mmHg and diastolic pressure under 90 mmHg, are classified as having borderline hypertension. People with blood pressure below these levels are considered 'normotensive.' However, these thresholds are somewhat arbitrary because blood pressure is a continuous variable, meaning there is no clear cut-off between normal and abnormal levels.
Most cases of hypertension fall under the category of 'essential' hypertension, where no specific underlying cause can be identified. This type of hypertension, unlike diseases with distinct causes, reflects a deviation in degree rather than kind—essentially, it is a quantitative problem. This concept can be challenging for doctors, who are trained in binary thinking, where conditions are often classified as present or absent based on clear-cut criteria. Essential hypertension defies this binary categorization, as it presents a spectrum of severity.
The definitions of hypertension are also pragmatic in nature. They are primarily designed to identify individuals who may benefit from specific treatments, whether pharmacologic or non-pharmacologic. For instance, the cut-off points for hypertension are often based on evidence from randomized controlled trials that show treatment benefits for people with blood pressure above certain levels. These benefits must outweigh the potential risks of treatment. However, such definitions can inadvertently exclude a large number of individuals who are still at increased risk due to their elevated blood pressure levels but fall below the threshold for therapeutic intervention. This highlights the need for a more nuanced approach to managing hypertension, one that takes into account the broader spectrum of risk rather than relying solely on rigid cut-offs for treatment eligibility.
Defining Hypertension: Challenges and Implications for Treatment
Paediatric Bipolar Disorder: Understanding and Managing Early-Onset Mood
Dysregulation
-
Paediatric bipolar disorder (PBD) is a severe mood disorder that manifests
in children and adolescents, marked by extreme shifts between manic or
hypomanic...